Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis

Supported by an Academic Clinical Fellow by the National Institute of Health Research and by a Wellcome Trust Ph.D. Training Fellowship for Clinicians (211042/Z/18/Z to T.C.). Potential conflict of interest: Dr. Ryan consults for Alnylam and Bond. Hereditary hemochromatosis (HH) is a relatively common autosomal recessive disorder of iron regulation that results in iron overload and its deposition in multiple organs. Complications include liver...